StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3034% below fair value
$3.18+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.04MP/E –Yield –

MiMedx operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

MiMedx's operating income for the twelve months ending Sep 30, 2026 was -$25.14M, down 146.7% year over year. For fiscal 2025 it was $63.89M, up 8.5% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $63.89M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$63.89M+8.5%
FY2024Dec 31, 2024$58.87M+58.6%
FY2023Dec 31, 2023$37.12M–
FY2022Dec 31, 2022-$14.73M–
FY2021Dec 31, 2021-$7.05M–
FY2020Dec 31, 2020-$45.40M–
FY2019Dec 31, 2019-$21.16M–
FY2018Dec 31, 2018-$3.92M-108.5%
FY2017Dec 31, 2017$46.22M+5128.8%
FY2016Dec 31, 2016$884.00K-96.4%
FY2015Dec 31, 2015$24.36M+243.2%
FY2014Dec 31, 2014$7.10M–
FY2013Dec 31, 2013-$2.64M–
FY2012Dec 31, 2012-$5.36M–
FY2011Dec 31, 2011-$9.76M–
FY2010Dec 31, 2010-$10.53M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$11.70M-152.7%
Q2 FY2026Jun 30, 2026-$18.47M-249.3%
Q1 FY2026Mar 31, 2026-$16.05M-294.5%
Q4 FY2025Dec 31, 2025$21.08M+90.7%
Q3 FY2025Sep 30, 2025$22.19M+98.8%
Q2 FY2025Jun 30, 2025$12.37M-47.2%
Q1 FY2025Mar 31, 2025$8.25M-37.5%
Q4 FY2024Dec 31, 2024$11.05M-28.6%
Q3 FY2024Sep 30, 2024$11.16M+0.3%
Q2 FY2024Jun 30, 2024$23.45M+116.3%
Q1 FY2024Mar 31, 2024$13.20M–
Q4 FY2023Dec 31, 2023$15.49M+36.9%
Q3 FY2023Sep 30, 2023$11.12M–
Q2 FY2023Jun 30, 2023$10.84M–
Q1 FY2023Mar 31, 2023-$340.00K–
Q4 FY2022Dec 31, 2022$11.31M+780.2%
Q3 FY2022Sep 30, 2022-$7.10M–
Q2 FY2022Jun 30, 2022-$9.64M–
Q1 FY2022Mar 31, 2022-$9.30M–
Q4 FY2021Dec 31, 2021$1.29M–
Q3 FY2021Sep 30, 2021-$1.08M–
Q2 FY2021Jun 30, 2021-$410.00K–
Q1 FY2021Mar 31, 2021-$6.85M–
Q4 FY2020Dec 31, 2020-$16.09M–
Q3 FY2020Sep 30, 2020-$9.71M-168.4%
Q2 FY2020Jun 30, 2020-$5.86M–
Q1 FY2020Mar 31, 2020-$13.74M–
Q4 FY2019Dec 31, 2019-$4.87M–
Q3 FY2019Sep 30, 2019$14.20M+3706.4%
Q2 FY2019Jun 30, 2019-$17.07M-1119.3%
Q1 FY2019Mar 31, 2019-$13.41M-551.5%
Q4 FY2018Dec 31, 2018-$8.94M-137.3%
Q3 FY2018Sep 30, 2018$373.00K-95.8%
Q2 FY2018Jun 30, 2018$1.68M-76.8%
Q1 FY2018Mar 31, 2018$2.97M-52.0%
Q4 FY2017Dec 31, 2017$23.98M–
Q3 FY2017Sep 30, 2017$8.84M–
Q2 FY2017Jun 30, 2017$7.21M–
Q1 FY2017Mar 31, 2017$6.19M–
Q4 FY2016Dec 31, 2016-$8.85M–

More MiMedx figures

See a number that looks wrong?